<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01154907</url>
  </required_header>
  <id_info>
    <org_study_id>VIBE-FGS</org_study_id>
    <nct_id>NCT01154907</nct_id>
  </id_info>
  <brief_title>Prevention of Female Genital Schistosomiasis (FGS) in Rural High-endemic South Africa</brief_title>
  <acronym>VIBE-FGS</acronym>
  <official_title>Prevention of HIV and Improved Diagnosis of Adolescent Genital Disease in Bilharzia Endemic KwaZulu-Natal, South Africa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of KwaZulu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Agder</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sorlandet Hospital HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universiteit Antwerpen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Schistosomiasis is a poverty-related water-transmitted parasitic disease affecting more that
      200 million people world wide. Infection with Schistosoma haematobium may cause Female
      Genital Schistosomiasis (FGS) with pathological lesions in the female genital tract,
      especially the cervix. Findings indicate that FGS is a hitherto under-diagnosed illness of
      young women in endemic poor tropical countries, deserving further attention. A
      cross-sectional study from Zimbabwe indicated that the pathologic genital lesions were
      unchanged two years after praziquantel treatment in adult women whereas in those who had been
      treated with praziquantel in childhood the prevalence of genital lesions was significantly
      lower. Furthermore, a higher prevalence of HIV was detected in women with FGS compared to
      those without. The proposed project aims at achieving a better understanding of how annual
      distribution of praziquantel to pre- and post-pubertal schoolgirls may prevent FGS. This
      information can be of use in current schistosomiasis control programs in the near term
      resulting in improved strategies for treatment. Preventing or reducing the risk of FGS and
      genital lesions will lead to improved reproductive health among in women living in
      schistosomiasis endemic areas.

      Project Goal: Contribute to a reduction of the global burden of female genital
      schistosomiasis (FGS) through improved knowledge about the prevention of gynecological
      lesions and through improved diagnosis of FGS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Provide a more extensive description, if desired. Avoid duplication of information to be
      recorded elsewhere, such as eligibility criteria or outcome measures
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HIV prevalence after anti-schistosomal treatment in adolescents</measure>
    <time_frame>31. December 2021</time_frame>
    <description>HIV prevalence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FGS prevalence and severity after anti-schistosomal treatment in adolescents</measure>
    <time_frame>31. December 2021</time_frame>
    <description>Clinical disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and laboratory indicators of urogenital schistosomiasis</measure>
    <time_frame>31. December 2018</time_frame>
    <description>Polymerase chain reaction (PCR) of vaginal lavage, Cytology, Circulation Anodic Antigen (CAA)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pocket Atlas of Female Genital Schistosomiasis</measure>
    <time_frame>31. December 2015</time_frame>
    <description>Published by WHO in English, French and Portuguese</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">6500</enrollment>
  <condition>Uro-genital Schistosomiasis</condition>
  <arm_group>
    <arm_group_label>Girls ages 10-12</arm_group_label>
    <description>In 18 rural schools in Ugu District, South Africa. Undergoing mass-treatment provided by the Department of Health.
Praziquantel was administered at 40mg/kg in annual mass-treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young adult women</arm_group_label>
    <description>In rural schools in three districts, South Africa. Undergoing mass-treatment provided by the Departments of Health.
Praziquantel was administered at 40mg/kg in annual mass-treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Praziquantel</intervention_name>
    <description>One day, 40mg/kg standard mass Praziquantel as recommended by WHO and local authorities</description>
    <arm_group_label>Girls ages 10-12</arm_group_label>
    <arm_group_label>Young adult women</arm_group_label>
    <other_name>Biltricide</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine, stool, blood, in the adults also vaginal lavage and Pap smears
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        A random sample of school girls in Ugu district, KwaZulu Natal, South Africa
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females in Schistosoma haematobium endemic areas

        Exclusion Criteria:

          -  Boys

          -  Pregnancy

          -  Allergic to praziquantel

          -  Severe disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>23 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eyrun F Kjetland, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital, University of KwaZulu-Natal (UKZN)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Myra Taylor, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UKZN/ Child Development Research Unit (CDRU)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jane Kvalsvig, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UKZN/ CDRU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Svein G Gundersen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Agder University Hospital / Sorlandet Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eyrun Floereke Kjetland, MD, PhD</last_name>
    <phone>+47 97008579</phone>
    <email>e.f.kjetland@medidin.uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Myra Taylor, MD, PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of KwaZulu Natal</name>
      <address>
        <city>Durban</city>
        <state>KwaZulu Natal</state>
        <zip>4000</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eyrun F. Kjetland, MD, PhD</last_name>
      <phone>+27 76 4920800</phone>
      <email>e.f.kjetland@medisin.uio.no</email>
    </contact>
    <contact_backup>
      <last_name>Myra Taylor, MD, PhD</last_name>
      <phone>+27 31 2604499</phone>
      <email>taylor@ukzn.ac.za</email>
    </contact_backup>
    <investigator>
      <last_name>Elisabeth Kleppa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <link>
    <url>http://brightresearch.org</url>
    <description>Project website</description>
  </link>
  <link>
    <url>http://who.int/schistosomiasis/en/</url>
    <description>WHO pocket atlas for Female Genital Schistosomiasis</description>
  </link>
  <reference>
    <citation>Baan M, Galappaththi-Arachchige HN, Gagai S, Aurlund CG, Vennervald BJ, Taylor M, van Lieshout L, Kjetland EF. The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa. PLoS Negl Trop Dis. 2016 May 3;10(5):e0004623. doi: 10.1371/journal.pntd.0004623. eCollection 2016 May.</citation>
    <PMID>27139497</PMID>
  </reference>
  <reference>
    <citation>Bustinduy AL, Friedman JF, Kjetland EF, Ezeamama AE, Kabatereine NB, Stothard JR, King CH. Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis. PLoS Negl Trop Dis. 2016 Sep 22;10(9):e0004946. doi: 10.1371/journal.pntd.0004946. eCollection 2016 Sep.</citation>
    <PMID>27658198</PMID>
  </reference>
  <results_reference>
    <citation>Pillay P, van Lieshout L, Taylor M, Sebitloane M, Zulu SG, Kleppa E, Roald B, Kjetland EF. Cervical cytology as a diagnostic tool for female genital schistosomiasis: Correlation to cervical atypia and Schistosoma polymerase chain reaction. Cytojournal. 2016 Apr 20;13:10. doi: 10.4103/1742-6413.180784. eCollection 2016.</citation>
    <PMID>27168759</PMID>
  </results_reference>
  <results_reference>
    <citation>Holmen S, Galappaththi-Arachchige HN, Kleppa E, Pillay P, Naicker T, Taylor M, Onsrud M, Kjetland EF, Albregtsen F. Characteristics of Blood Vessels in Female Genital Schistosomiasis: Paving the Way for Objective Diagnostics at the Point of Care. PLoS Negl Trop Dis. 2016 Apr 13;10(4):e0004628. doi: 10.1371/journal.pntd.0004628. eCollection 2016 Apr.</citation>
    <PMID>27073857</PMID>
  </results_reference>
  <results_reference>
    <citation>Holmen SD, Kleppa E, Lillebø K, Pillay P, van Lieshout L, Taylor M, Albregtsen F, Vennervald BJ, Onsrud M, Kjetland EF. The first step toward diagnosing female genital schistosomiasis by computer image analysis. Am J Trop Med Hyg. 2015 Jul;93(1):80-6. doi: 10.4269/ajtmh.15-0071. Epub 2015 Apr 27.</citation>
    <PMID>25918212</PMID>
  </results_reference>
  <results_reference>
    <citation>Kleppa E, Klinge KF, Galaphaththi-Arachchige HN, Holmen SD, Lillebø K, Onsrud M, Gundersen SG, Taylor M, Ndhlovu P, Kjetland EF. Schistosoma haematobium infection and CD4+ T-cell levels: a cross-sectional study of young South African women. PLoS One. 2015 Mar 13;10(3):e0119326. doi: 10.1371/journal.pone.0119326. eCollection 2015.</citation>
    <PMID>25768005</PMID>
  </results_reference>
  <results_reference>
    <citation>Holmen SD, Kjetland EF, Taylor M, Kleppa E, Lillebø K, Gundersen SG, Onsrud M, Albregtsen F. Colourimetric image analysis as a diagnostic tool in female genital schistosomiasis. Med Eng Phys. 2015 Mar;37(3):309-14. doi: 10.1016/j.medengphy.2014.12.007. Epub 2015 Jan 24.</citation>
    <PMID>25630808</PMID>
  </results_reference>
  <results_reference>
    <citation>Kildemoes AO, Kjetland EF, Zulu SG, Taylor M, Vennervald BJ. Schistosoma haematobium infection and asymptomatic bacteriuria in young South African females. Acta Trop. 2015 Apr;144:19-23. doi: 10.1016/j.actatropica.2015.01.008. Epub 2015 Jan 24.</citation>
    <PMID>25623258</PMID>
  </results_reference>
  <results_reference>
    <citation>Norseth HM, Ndhlovu PD, Kleppa E, Randrianasolo BS, Jourdan PM, Roald B, Holmen SD, Gundersen SG, Bagratee J, Onsrud M, Kjetland EF. The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3229. doi: 10.1371/journal.pntd.0003229. eCollection 2014.</citation>
    <PMID>25412334</PMID>
  </results_reference>
  <results_reference>
    <citation>Kleppa E, Holmen SD, Lillebø K, Kjetland EF, Gundersen SG, Taylor M, Moodley P, Onsrud M. Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa. Sex Transm Infect. 2015 Mar;91(2):124-9. doi: 10.1136/sextrans-2014-051674. Epub 2014 Oct 3.</citation>
    <PMID>25281761</PMID>
  </results_reference>
  <results_reference>
    <citation>Kjetland EF, Norseth HM, Taylor M, Lillebø K, Kleppa E, Holmen SD, Andebirhan A, Yohannes TH, Gundersen SG, Vennervald BJ, Bagratee J, Onsrud M, Leutscher PD. Classification of the lesions observed in female genital schistosomiasis. Int J Gynaecol Obstet. 2014 Dec;127(3):227-8. doi: 10.1016/j.ijgo.2014.07.014. Epub 2014 Aug 13.</citation>
    <PMID>25179171</PMID>
  </results_reference>
  <results_reference>
    <citation>Kleppa E, Ramsuran V, Zulu S, Karlsen GH, Bere A, Passmore JA, Ndhlovu P, Lillebø K, Holmen SD, Onsrud M, Gundersen SG, Taylor M, Kjetland EF, Ndung'u T. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract. PLoS One. 2014 Jun 4;9(6):e98593. doi: 10.1371/journal.pone.0098593. eCollection 2014.</citation>
    <PMID>24896815</PMID>
  </results_reference>
  <results_reference>
    <citation>Pillay P, Taylor M, Zulu SG, Gundersen SG, Verweij JJ, Hoekstra P, Brienen EA, Kleppa E, Kjetland EF, van Lieshout L. Real-time polymerase chain reaction for detection of Schistosoma DNA in small-volume urine samples reflects focal distribution of urogenital Schistosomiasis in primary school girls in KwaZulu Natal, South Africa. Am J Trop Med Hyg. 2014 Mar;90(3):546-52. doi: 10.4269/ajtmh.13-0406. Epub 2014 Jan 27.</citation>
    <PMID>24470560</PMID>
  </results_reference>
  <results_reference>
    <citation>Hegertun IE, Sulheim Gundersen KM, Kleppa E, Zulu SG, Gundersen SG, Taylor M, Kvalsvig JD, Kjetland EF. S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa. PLoS Negl Trop Dis. 2013;7(3):e2104. doi: 10.1371/journal.pntd.0002104. Epub 2013 Mar 21.</citation>
    <PMID>23556009</PMID>
  </results_reference>
  <results_reference>
    <citation>Galappaththi-Arachchige HN, Amlie Hegertun IE, Holmen S, Qvigstad E, Kleppa E, Sebitloane M, Ndhlovu PD, Vennervald BJ, Gundersen SG, Taylor M, Kjetland EF. Association of Urogenital Symptoms with History of Water Contact in Young Women in Areas Endemic for S. haematobium. A Cross-Sectional Study in Rural South Africa. Int J Environ Res Public Health. 2016 Nov 14;13(11). pii: E1135.</citation>
    <PMID>27854250</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2010</study_first_submitted>
  <study_first_submitted_qc>June 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2010</study_first_posted>
  <last_update_submitted>September 18, 2017</last_update_submitted>
  <last_update_submitted_qc>September 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Eyrun Floerecke Kjetland</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Uro-genital schistosomiasis</keyword>
  <keyword>Female</keyword>
  <keyword>South Africa</keyword>
  <keyword>Rural</keyword>
  <keyword>Sexually transmitted diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schistosomiasis</mesh_term>
    <mesh_term>Schistosomiasis haematobia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Praziquantel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Still collecting and publishing</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

